These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 10835685
61. Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcalphaRI (CD89) improves in vitro clearance by gingival crevicular neutrophils. Kobayashi T, Takauchi A, van Spriel AB, Vilé HA, Hayakawa M, Shibata Y, Abiko Y, van de Winkel JG, Yoshie H. Vaccine; 2004 Dec 16; 23(5):585-94. PubMed ID: 15542178 [Abstract] [Full Text] [Related]
62. CD89: the human myeloid IgA Fc receptor. Morton HC, Brandtzaeg P. Arch Immunol Ther Exp (Warsz); 2001 Dec 16; 49(3):217-29. PubMed ID: 11478396 [Abstract] [Full Text] [Related]
65. Secretory IgA-Fcα receptor interaction modulating phagocytosis and microbicidal activity by phagocytes in human colostrum of diabetics. França EL, Morceli G, Fagundes DL, Rudge MV, Calderon Ide M, Honorio-França AC. APMIS; 2011 Oct 16; 119(10):710-9. PubMed ID: 21917008 [Abstract] [Full Text] [Related]
66. Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA. Van Spriel AB, Leusen JH, Vilé H, Van De Winkel JG. J Immunol; 2002 Oct 01; 169(7):3831-6. PubMed ID: 12244179 [Abstract] [Full Text] [Related]
67. Molecular characteristics of IgA and IgM Fc binding to the Fcalpha/muR. Cho Y, Usui K, Honda S, Tahara-Hanaoka S, Shibuya K, Shibuya A. Biochem Biophys Res Commun; 2006 Jun 23; 345(1):474-8. PubMed ID: 16681999 [Abstract] [Full Text] [Related]
68. Functional expression of IgA receptor FcalphaRI on human platelets. Qian K, Xie F, Gibson AW, Edberg JC, Kimberly RP, Wu J. J Leukoc Biol; 2008 Dec 23; 84(6):1492-500. PubMed ID: 18784345 [Abstract] [Full Text] [Related]
69. Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells. Pascal V, Laffleur B, Debin A, Cuvillier A, van Egmond M, Drocourt D, Imbertie L, Pangault C, Tarte K, Tiraby G, Cogné M. Haematologica; 2012 Nov 23; 97(11):1686-94. PubMed ID: 22689689 [Abstract] [Full Text] [Related]
73. Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake. Tacken PJ, Batenburg JJ. Immunology; 2006 Apr 15; 117(4):494-501. PubMed ID: 16556263 [Abstract] [Full Text] [Related]
74. The role of IgA and IgA Fc receptors as anti-inflammatory agents. Monteiro RC. J Clin Immunol; 2010 May 15; 30 Suppl 1():S61-4. PubMed ID: 20405182 [Abstract] [Full Text] [Related]
76. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions. Kanamaru Y, Blank U, Monteiro RC. Contrib Nephrol; 2007 May 15; 157():148-52. PubMed ID: 17495454 [Abstract] [Full Text] [Related]
77. Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies. van der Steen LP, Bakema JE, Sesarman A, Florea F, Tuk CW, Kirtschig G, Hage JJ, Sitaru C, van Egmond M. J Immunol; 2012 Aug 15; 189(4):1594-601. PubMed ID: 22802416 [Abstract] [Full Text] [Related]
78. Pentraxins and IgA share a binding hot-spot on FcαRI. Lu J, Marjon KD, Mold C, Marnell L, Du Clos TW, Sun P. Protein Sci; 2014 Apr 15; 23(4):378-86. PubMed ID: 24407959 [Abstract] [Full Text] [Related]